Douglas Millar is currently the Market Access Lead for Cardiovascular and Women's Health at Bayer, a position they have held since 2025. Prior to this role, Douglas worked as a Consultant on a freelance basis in 2025 and served as an HTA Strategist at Commercial Eyes Pty Ltd from 2020 to 2023. Their extensive experience includes leadership roles in international payer strategy at Roche Pharmaceuticals from 2011 to 2016 and as an Associate Director of Market Access at BioMarin Pharmaceutical Inc. in 2024. Douglas began their career at Allergan as a Decision Support Analyst in R&D from 1999 to 2000 and held various positions at Roche, including Business Analyst and Senior Health Economist, before transitioning to focus on market access strategies.
This person is not in the org chart
This person is not in any teams
This person is not in any offices